You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TKI

Showing 1151 - 1175 of 1,196
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GastroEsophageal Cancer Trial in Germany (Lapatinib, Lapatinib plus capecitabine)

Terminated
  • GastroEsophageal Cancer
  • Berlin, Germany
  • +15 more
Jul 1, 2014

EGFR Mutation Positive NSCLC Trial in Seoul (EGFR TKIs (gefitinib, erlotinib, afatinib, et al))

Unknown status
  • EGFR Mutation Positive Non-small Cell Lung Cancer
  • EGFR TKIs (gefitinib, erlotinib, afatinib, et al)
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 25, 2013

NSCLC Trial in Singapore (Gefitinib, Hydroxychloroquine)

Unknown status
  • Non-small Cell Lung Cancer
  • Gefitinib, Hydroxychloroquine
  • Singapore, Singapore
    National University Hospital
Dec 8, 2013

NSCLC Trial in Urumqi (gemcitabine; cisplatin or carboplatin; erlotinib, erlotinib)

Unknown status
  • Non-Small Cell Lung Cancer
  • gemcitabine; cisplatin or carboplatin; erlotinib
  • erlotinib
  • Urumqi, Xinjiang, China
    Xinjiang medical university
Nov 28, 2013

Anti-microtubule and Non-anti-microtubule as 3th Therapy After

Completed
  • Cancer
    • Gueishan Township, Taiwan
      Research Site
    Sep 19, 2012

    Pulmonary Arterial Hypertension Treated With Nilotinib

    Withdrawn
    • PAH
      • Cleveland, Ohio
        Cleveland Clinic
      Feb 3, 2014

      Efficacy of EGFR TKIs in Patients With Rare EGFR-mutated NSCLC

      Unknown status
      • Lung Neoplasms
        • Ulsan, Korea, Republic of
          Ulsan University Hospital
        Dec 10, 2013

        Chronic Myelogenous Leukemia, Short Stature Trial in Chandigarh (Growth Hormone)

        Unknown status
        • Chronic Myelogenous Leukemia
        • Short Stature
        • Growth Hormone
        • Chandigarh, UT, India
          Postgraduate Institute of Medical Education and Research
        Jul 12, 2013

        Non Small Cell Lung Cancer Trial in Taipei (MK2206)

        Unknown status
        • Non Small Cell Lung Cancer
        • Taipei, Taiwan
          National Taiwan University Hospital
        May 1, 2013

        Non-Small-Cell Lung Carcinoma Trial in Goyang-si (Study treatment)

        Unknown status
        • Non-Small-Cell Lung Carcinoma
        • Study treatment
        • Goyang-si, Gyeonggi-do, Korea, Republic of
          National Cancer Center
        Nov 13, 2013

        Non Small Cell Lung Cancer Trial in Beijing (combined group, Sequenced group)

        Unknown status
        • Non Small Cell Lung Cancer
        • combined group
        • Sequenced group
        • Beijing, China
          Department of Respiratory Medicne, Peking Union Medical Hospital
        Dec 7, 2012

        NSCLC Trial in Guangzhou (neoadjuvant erlotinib therapy, neoadjuvant gemcitabine/carboplatin therapy)

        Completed
        • Carcinoma, Non-Small-Cell Lung
        • neoadjuvant erlotinib therapy
        • neoadjuvant gemcitabine/carboplatin therapy
        • Guangzhou, Guangdong, China
          Guangdong General Hospital
        Jun 23, 2013

        CML Trial in Petah tikva (Treatment modification based on molecular response at 3 months)

        Unknown status
        • CML
        • Treatment modification based on molecular response at 3 months
        • Petah tikva, Israel
          Rabin Medical Center
        Jan 7, 2013

        NSCLC, Effects of Chemo Trial in Beijing (Gefitinib group, Vinorelbine, Ifosfamide, Mesna)

        Unknown status
        • Non-small Cell Lung Cancer
        • Effects of Chemotherapy
        • Gefitinib group
        • Vinorelbine, Ifosfamide, Mesna
        • Beijing, Beijing, China
          Department of Respiratory Medicine, Peking Union Medical College
        Dec 12, 2012

        Gastrointestinal Stromal Tumors Trial in Philadelphia (Nilotinib)

        Terminated
        Has Results
        • Gastrointestinal Stromal Tumors
        • Philadelphia, Pennsylvania
          Fox Chase Cancer Center
        Apr 15, 2013

        De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine

        Unknown status
        • NSCLC
          • (no location specified)
          Sep 26, 2012

          NSCLC Trial in Seoul (Gefitinib)

          Unknown status
          • Non-small Cell Lung Cancer
          • Seoul, Korea, Republic of
            Asan Medical Center
          Jan 26, 2013

          NSCLC Trial in Beijing (Gefitinib, Docetaxel)

          Unknown status
          • Non-small Cell Lung Cancer
          • Beijing, Beijing, China
            Department of Respiratory Medicine, Peking Union Medical College
          Dec 19, 2012

          BRAFV600E Intratumor Heterogeneity in Thyroid Cancer Treated

          Unknown status
          • Differentiated Thyroid Cancer
            • Baronissi, Salerno, Italy
              Department of Medicine and Surgery, Univeristy of Salerno
            Oct 20, 2012

            Creatinine Phosphokinase Increase in Solid Tumors Treated by

            Completed
            • Cancer
            • Solid Tumor
            • CPK dosage
            • Clinical exam
            • Angers, France
            • +26 more
            Jun 6, 2012

            Non-small-cell Lung Cancer Trial in Shanghai (Gefitinib)

            Unknown status
            • Non-small-cell Lung Cancer
            • Shanghai, China
              Fudan University Shanghai Cancer Center
            May 27, 2013

            NSCLC Trial in Hwasun-gun (Gefitinib retreatment)

            Completed
            Has Results
            • Carcinoma, Non-Small-Cell Lung
            • Gefitinib retreatment
            • Hwasun-gun, Jeonnam, Korea, Republic of
              Chonnam National University Hwasun Hospital
            Jan 22, 2013

            Lung Cancer Trial in Chengdu (cisplatin and gemcitabine combination with Bevacizumab, Gemcitabine combined with cisplatin chemo)

            Unknown status
            • Lung Cancer
            • cisplatin and gemcitabine combination with Bevacizumab
            • Gemcitabine combined with cisplatin chemotherapy
            • Chengdu, Sichuan, China
            • +1 more
            Feb 11, 2013

            Smoking Pattern and Clinical Efficacy of Epidermal Growth Factor

            Completed
            • Non Small Cell Lung Cancer
              • Changhua, Taiwan
              • +5 more
              Sep 26, 2011

              Lung Cancer Trial in Singapore (Characterise the molecular epidemiology of lung adenocarcinoma in multi-ethnic asian phenotypes)

              Unknown status
              • Lung Cancer
              • Characterise the molecular epidemiology of lung adenocarcinoma in multi-ethnic asian phenotypes
              • Singapore, Singapore
                National University Hospital/ National University of Singapore
              Jan 21, 2013